Bell & Brown Wealth Advisors LLC bought a new position in Bristol-Myers Squibb (NYSE:BMY – Free Report) in the 4th quarter, HoldingsChannel reports. The fund bought 50,552 shares of the biopharmaceutical company’s stock, valued at approximately $2,594,000. Other institutional investors and hedge funds have also recently bought and sold shares of the company. McClarren Financial […]
Peak Asset Management LLC trimmed its holdings in Bristol-Myers Squibb (NYSE:BMY – Free Report) by 3.4% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 53,308 shares of the biopharmaceutical company’s stock after selling 1,856 shares during the quarter. Peak Asset Management LLC’s holdings […]
S&CO Inc. trimmed its position in shares of Bristol-Myers Squibb (NYSE:BMY – Free Report) by 13.7% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 279,270 shares of the biopharmaceutical company’s stock after selling 44,297 shares during the period. Bristol-Myers Squibb makes […]
Alta Wealth Advisors LLC cut its holdings in shares of Bristol-Myers Squibb (NYSE:BMY – Free Report) by 3.9% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 19,675 shares of the biopharmaceutical company’s stock after selling 796 shares during the quarter. Alta Wealth Advisors […]
HCR Wealth Advisors lifted its position in shares of Bristol-Myers Squibb (NYSE:BMY – Free Report) by 10.6% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 14,618 shares of the biopharmaceutical company’s stock after acquiring an additional 1,405 shares during […]